These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
258 related articles for article (PubMed ID: 28526636)
1. Rebamipide ameliorates radiation-induced intestinal injury in a mouse model. Shim S; Jang HS; Myung HW; Myung JK; Kang JK; Kim MJ; Lee SB; Jang WS; Lee SJ; Jin YW; Lee SS; Park S Toxicol Appl Pharmacol; 2017 Aug; 329():40-47. PubMed ID: 28526636 [TBL] [Abstract][Full Text] [Related]
2. Rebamipide alleviates radiation-induced colitis through improvement of goblet cell differentiation in mice. Jang H; Park S; Lee J; Myung JK; Jang WS; Lee SJ; Myung H; Lee C; Kim H; Lee SS; Jin YW; Shim S J Gastroenterol Hepatol; 2018 Apr; 33(4):878-886. PubMed ID: 29047150 [TBL] [Abstract][Full Text] [Related]
3. Rebamipide Promotes the Regeneration of Aspirin-Induced Small-Intestine Mucosal Injury through Accumulation of β-Catenin. Lai Y; Zhong W; Yu T; Xia ZS; Li JY; Ouyang H; Shan TD; Yang HS; Chen QK PLoS One; 2015; 10(7):e0132031. PubMed ID: 26135128 [TBL] [Abstract][Full Text] [Related]
4. Melatonin and roentgen irradiation-induced acute radiation enteritis in Albino rats: an animal model. Hussein MR; Abu-Dief EE; Kamel E; Abou El-Ghait AT; Abdulwahed SR; Ahmad MH Cell Biol Int; 2008 Nov; 32(11):1353-61. PubMed ID: 18762261 [TBL] [Abstract][Full Text] [Related]
5. Rebamipide ameliorates indomethacin-induced small intestinal injury in rats via the inhibition of matrix metalloproteinases activity. Yamada S; Naito Y; Takagi T; Mizushima K; Horie R; Fukumoto K; Inoue K; Harusato A; Uchiyama K; Handa O; Yagi N; Ichikawa H; Yoshikawa T J Gastroenterol Hepatol; 2012 Dec; 27(12):1816-24. PubMed ID: 23020299 [TBL] [Abstract][Full Text] [Related]
6. Protection of human corneal epithelial cells from TNF-α-induced disruption of barrier function by rebamipide. Kimura K; Morita Y; Orita T; Haruta J; Takeji Y; Sonoda KH Invest Ophthalmol Vis Sci; 2013 Apr; 54(4):2572-760. PubMed ID: 23482463 [TBL] [Abstract][Full Text] [Related]
7. Rebamipide increases barrier function and attenuates TNFα-induced barrier disruption and cytokine expression in human corneal epithelial cells. Tanaka H; Fukuda K; Ishida W; Harada Y; Sumi T; Fukushima A Br J Ophthalmol; 2013 Jul; 97(7):912-6. PubMed ID: 23603753 [TBL] [Abstract][Full Text] [Related]
8. Resveratrol attenuates radiation enteritis through the SIRT1/FOXO3a and PI3K/AKT signaling pathways. Qin H; Zhang H; Zhang X; Zhang S; Zhu S; Wang H Biochem Biophys Res Commun; 2021 May; 554():199-205. PubMed ID: 33812084 [TBL] [Abstract][Full Text] [Related]
9. Keratinocyte growth factor pretreatment prevents radiation-induced intestinal damage in a mouse model. Cai Y; Wang W; Liang H; Sun L; Teitelbaum DH; Yang H Scand J Gastroenterol; 2013 Apr; 48(4):419-26. PubMed ID: 23464848 [TBL] [Abstract][Full Text] [Related]
10. Protective effect and mechanism of rebamipide on NSAIDs associated small bowel injury. Xu N; Zhang C; Jing L; Mou S; Cao X; Yu Z Int Immunopharmacol; 2021 Jan; 90():107136. PubMed ID: 33218942 [TBL] [Abstract][Full Text] [Related]
11. Rapid disruption of intestinal epithelial tight junction and barrier dysfunction by ionizing radiation in mouse colon in vivo: protection by N-acetyl-l-cysteine. Shukla PK; Gangwar R; Manda B; Meena AS; Yadav N; Szabo E; Balogh A; Lee SC; Tigyi G; Rao R Am J Physiol Gastrointest Liver Physiol; 2016 May; 310(9):G705-15. PubMed ID: 26822914 [TBL] [Abstract][Full Text] [Related]
12. Rebamipide suppresses diclofenac-induced intestinal permeability via mitochondrial protection in mice. Diao L; Mei Q; Xu JM; Liu XC; Hu J; Jin J; Yao Q; Chen ML World J Gastroenterol; 2012 Mar; 18(10):1059-66. PubMed ID: 22416180 [TBL] [Abstract][Full Text] [Related]
13. TLR4 Agonist Monophosphoryl Lipid A Alleviated Radiation-Induced Intestinal Injury. Guo J; Liu Z; Zhang D; Chen Y; Qin H; Liu T; Liu C; Cui J; Li B; Yang Y; Cai J; Gao F J Immunol Res; 2019; 2019():2121095. PubMed ID: 31275998 [TBL] [Abstract][Full Text] [Related]
14. Protective effects of tauroursodeoxycholate against radiation-induced intestinal injury in a mouse model. Lee J; Jeon BS; Kang S; Son Y; Lim YB; Bae MJ; Jo WS; Lee CG; Shin IS; Moon C; Lee HJ; Kim JS Biochem Biophys Res Commun; 2024 Sep; 724():150226. PubMed ID: 38865815 [TBL] [Abstract][Full Text] [Related]
15. Vanillin derivative VND3207 activates DNA-PKcs conferring protection against radiation-induced intestinal epithelial cells injury in vitro and in vivo. Li M; Lang Y; Gu MM; Shi J; Chen BPC; Yu L; Zhou PK; Shang ZF Toxicol Appl Pharmacol; 2020 Jan; 387():114855. PubMed ID: 31830491 [TBL] [Abstract][Full Text] [Related]
16. Nontoxic concentrations of OTA aggravate DON-induced intestinal barrier dysfunction in IPEC-J2 cells via activation of NF-κB signaling pathway. Ying C; Hong W; Nianhui Z; Chunlei W; Kehe H; Cuiling P Toxicol Lett; 2019 Sep; 311():114-124. PubMed ID: 31026484 [TBL] [Abstract][Full Text] [Related]
17. Sodium alginate ameliorates indomethacin-induced gastrointestinal mucosal injury via inhibiting translocation in rats. Yamamoto A; Itoh T; Nasu R; Nishida R World J Gastroenterol; 2014 Mar; 20(10):2641-52. PubMed ID: 24627600 [TBL] [Abstract][Full Text] [Related]
18. Rebamipide suppresses PolyI:C-stimulated cytokine production in human conjunctival epithelial cells. Ueta M; Sotozono C; Yokoi N; Kinoshita S J Ocul Pharmacol Ther; 2013 Sep; 29(7):688-93. PubMed ID: 23662915 [TBL] [Abstract][Full Text] [Related]
19. Rebamipide prevents peripheral arthritis and intestinal inflammation by reciprocally regulating Th17/Treg cell imbalance in mice with curdlan-induced spondyloarthritis. Min HK; Kim JK; Lee SY; Kim EK; Lee SH; Lee J; Kwok SK; Cho ML; Park SH J Transl Med; 2016 Jun; 14(1):190. PubMed ID: 27350608 [TBL] [Abstract][Full Text] [Related]
20. Rebamipide inhibits indomethacin-induced small intestinal injury: possible involvement of intestinal microbiota modulation by upregulation of α-defensin 5. Tanigawa T; Watanabe T; Otani K; Nadatani Y; Ohkawa F; Sogawa M; Yamagami H; Shiba M; Watanabe K; Tominaga K; Fujiwara Y; Takeuchi K; Arakawa T Eur J Pharmacol; 2013 Mar; 704(1-3):64-9. PubMed ID: 23428631 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]